REGISTER for the 27th Annual Meeting in Baltimore, MD or virtually! We look forward to seeing you May 7-11.
Want to kick off the 26th Annual Meeting with an extra half day of learning? Register for one of seven expert-led workshops.
Join us for a workshop on Tuesday, May 16, the first day of the 2023 Annual Meeting. All workshops take place from 8 a.m. to 12 p.m. (PT). Workshop registrants will have on-demand acess to sessions for 30 days. You must be registered for the meeting to add a workshop. Here are a few highlights:
Speakers will outline the necessary steps to becoming a site for AAV gene therapy trials and discuss what is needed to treat and monitor patients before, during, and after therapy treatments.
Topics & Speakers
Preclinical/IND-enabling Basics of AAV Biology and GT Vectors Preclinical Enablement and the IB Mark A. Kay, MD, PhD, Stanford University
Regulatory & Site Initiation IBC and IRB Site Activation and Pharmacy Eric Crombez, MD, Ultragenyx
Clinical Protocol Implementation: Who Sees the Patient and What Is Needed? Clinical Infrastructure Treating the Patient/Acute Monitoring Phase I/II vs III vs IV Kimberly Goodspeed, MD, UT-Southwestern
Follow up and Long-term Toxicity: What needs to be followed for follow up? Denise E. Sabatino, PhD, The Children’s Hospital of Philadelphia
Small group discussion
Large group summary
Is this your first time at the Annual Meeting? Or your first time back in person in a while? If so, we'll help you navigate and make the most of your time at the largest gathering of CGT professionals. Bring your questions for our speakers!
Please note: This session is intended for in-person attendees. Virtual attendees will not be able to participate in small group discussions.
How to Network at a Conference Hildegard Buning, PhD, Hannover Medical School, Germany
How to Maximize Your Use of Social Media Emily Walsh, PhD, Tremont Therapeutics
Small group breakout sessions/Q&A
Spinning a company straight out of academia can be a daunting task for first-time technical founders. Come hear first-hand experience from academic founders and VCs who put "first money in" with actionable insights you can implement right away.
IP/Contracts (getting legal representation, MTA, option/license) Sabrina D. Poulos, JD Goodwin Procter, LLP
Money (dilutive vs non-dilutive, angels, grants): Successful Operator-to-VC Chris Garabedian, Xontogeny and Perceptive VC Firm
How to Vet if Your Idea is Worthy of Starting a Startup Nicole K. Paulk, PhD, Siren Biotechnology and University of California, San Francisco
Defining Milestones for Program Development & Successful Fundraising Melissa A. Kotterman, PhD, Iris Medicines, Inc.
Team building (how many scientists and when, where are you going to find them, mentors/advisors) and how to decide between consultants and contractors and PT hires and FT hires Eric Kelsic, PhD, Dyno Therapeutics
Founder stories
Mentoring with the panelists
Read descriptions for the rest of the workshops here. You must be registered for the meeting to add a workshop!
Devin Rose is ASGCT's communications manager.
May 7-11, 2024 | Baltimore, MD
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico